Clinical Trial Update: Targeting of Immune Response After Pneumococcal Vaccination [Phase 4]

View source ↗

Summary

Phase 4 study assessing the immune response after pneumococcal vaccination has completed, conducted at Helsinki University Central Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Pneumonia

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Pneumococcal Pneumonia | Phase 4 | Status: COMPLETED